You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 17, May 2, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Treatment Adherence
 •Psychiatry
 •Depression
 •Cardiovascular Disease/ Myocardial Infarction
 •Adherence
 •Alert me on articles by topic

Mortality and Adherence to Pharmacotherapy After Acute Myocardial Infarction

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Rasmussen and colleagues1 reported reduced mortality in elderly survivors of MI who were adherent to statins and beta-blockers, but no association between adherence and mortality for CCBs. The rate of cancer-related admissions did not differ between adherers and nonadherers taking any of these medications. They concluded that healthy behaviors do not confer mortality benefits in a real-world population. However, previous studies showed that good adherence to placebo was associated with longer survival,2 and lifestyle adaptations such as smoking abstinence and exercise may account for the mortality benefit of those who adhere to drug regimens.3 The discordant results of the current study may be due to bias introduced by the choice of medications and the methods of detecting outcomes.

Some CCBs may increase cardiovascular mortality after MI.4 Thus, a positive effect of healthy behaviors in CCB-adherent patients could have been obscured by harmful effects of the drug, . . . [Full Text of this Article]

Mitsuyo Kinjo, MD, MPH
mitsuyos220@worldnet.att.net

Kiyoshi Kinjo, MD, MS
Teine Keijinkai Hospital
Teine-ku
Sapporo City, Japan

Isao Iwata, MD, EdM
Caritas Carney Hospital
Dorchester, Mass

Soko Setoguchi, MD, DrPH
Division of Pharmacoepidemiology
Brigham and Women's Hospital
Boston, Mass


RELATED LETTERS

Mortality and Adherence to Pharmacotherapy After Acute Myocardial Infarction
Kapil Parakh, David E. Bush, Roy C. Ziegelstein, Brett D. Thombs, and James A. Fauerbach
JAMA. 2007;297(17):1877.
EXTRACT | FULL TEXT  

Mortality and Adherence to Pharmacotherapy After Acute Myocardial Infarction—Reply
Jeppe N. Rasmussen and David A. Alter
JAMA. 2007;297(17):1878.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction
Jeppe N. Rasmussen, Alice Chong, and David A. Alter
JAMA. 2007;297(2):177-186.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.